1 Min Read
March 21 (Reuters) - THERANEXUS SA:
* ANNOUNCES A SUCCESSFUL CLINICAL PHARMACOKINETIC STUDY AS PART OF DEVELOPMENT OF ITS DRUG CANDIDATES THN201 AND THN101 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.